149 related articles for article (PubMed ID: 12509987)
1. Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferase.
Kawamura A; Sandy J; Upton A; Noble M; Sim E
Protein Expr Purif; 2003 Jan; 27(1):75-84. PubMed ID: 12509987
[TBL] [Abstract][Full Text] [Related]
2. Mutational and expression analysis of tbnat and its response to isoniazid.
Sholto-Douglas-Vernon C; Sandy J; Victor TC; Sim E; Helden PD
J Med Microbiol; 2005 Dec; 54(Pt 12):1189-1197. PubMed ID: 16278433
[TBL] [Abstract][Full Text] [Related]
3. Arylamine N-acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolism.
Upton AM; Mushtaq A; Victor TC; Sampson SL; Sandy J; Smith DM; van Helden PV; Sim E
Mol Microbiol; 2001 Oct; 42(2):309-17. PubMed ID: 11703656
[TBL] [Abstract][Full Text] [Related]
4. Evidence towards the role of arylamine N-acetyltransferase in Mycobacterium smegmatis and development of a specific antiserum against the homologous enzyme of Mycobacterium tuberculosis.
Payton M; Gifford C; Schartau P; Hagemeier C; Mushtaq A; Lucas S; Pinter K; Sim E
Microbiology (Reading); 2001 Dec; 147(Pt 12):3295-302. PubMed ID: 11739761
[TBL] [Abstract][Full Text] [Related]
5. Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance.
Payton M; Auty R; Delgoda R; Everett M; Sim E
J Bacteriol; 1999 Feb; 181(4):1343-7. PubMed ID: 9973365
[TBL] [Abstract][Full Text] [Related]
6. The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
Sandy J; Mushtaq A; Kawamura A; Sinclair J; Sim E; Noble M
J Mol Biol; 2002 May; 318(4):1071-83. PubMed ID: 12054803
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Arylamine N-acetyltransferase from Mycobacterium marinum and Mycobacterium tuberculosis.
Fullam E; Kawamura A; Wilkinson H; Abuhammad A; Westwood I; Sim E
Protein J; 2009 Aug; 28(6):281-93. PubMed ID: 19636684
[TBL] [Abstract][Full Text] [Related]
8. Binding of the anti-tubercular drug isoniazid to the arylamine N-acetyltransferase protein from Mycobacterium smegmatis.
Sandy J; Holton S; Fullam E; Sim E; Noble M
Protein Sci; 2005 Mar; 14(3):775-82. PubMed ID: 15722451
[TBL] [Abstract][Full Text] [Related]
9. Expression and purification of the rifamycin amide synthase, RifF, an enzyme homologous to the prokaryotic arylamine N-acetyltransferases.
Pompeo F; Mushtaq A; Sim E
Protein Expr Purif; 2002 Feb; 24(1):138-51. PubMed ID: 11812235
[TBL] [Abstract][Full Text] [Related]
10. Sequence and structural characterization of tbnat gene in isoniazid-resistant Mycobacterium tuberculosis: identification of new mutations.
Coelho MB; Costa ER; Vasconcellos SE; Linck N; Ramos RM; Amorim HL; Suffys PN; Santos AR; Silva PE; Ramos DF; Silva MS; Rossetti ML
Mutat Res; 2011 Jul; 712(1-2):33-9. PubMed ID: 21514309
[TBL] [Abstract][Full Text] [Related]
11. Characterization of an oxidoreductase from the arylamine N-acetyltransferase operon in Mycobacterium smegmatis.
Evangelopoulos D; Cronin N; Daviter T; Sim E; Keep NH; Bhakta S
FEBS J; 2011 Dec; 278(24):4824-32. PubMed ID: 21972977
[TBL] [Abstract][Full Text] [Related]
12. Expression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase.
Westwood IM; Holton SJ; Rodrigues-Lima F; Dupret JM; Bhakta S; Noble ME; Sim E
Biochem J; 2005 Jan; 385(Pt 2):605-12. PubMed ID: 15447630
[TBL] [Abstract][Full Text] [Related]
13. Improvement of the expression and purification of Mycobacterium tuberculosis arylamine N-acetyltransferase (TBNAT) a potential target for novel anti-tubercular agents.
Abuhammad A; Lack N; Schweichler J; Staunton D; Sim RB; Sim E
Protein Expr Purif; 2011 Dec; 80(2):246-52. PubMed ID: 21767648
[TBL] [Abstract][Full Text] [Related]
14. Kinetic and chemical mechanism of arylamine N-acetyltransferase from Mycobacterium tuberculosis.
Sikora AL; Frankel BA; Blanchard JS
Biochemistry; 2008 Oct; 47(40):10781-9. PubMed ID: 18795795
[TBL] [Abstract][Full Text] [Related]
15. Structure of arylamine N-acetyltransferase from Mycobacterium tuberculosis determined by cross-seeding with the homologous protein from M. marinum: triumph over adversity.
Abuhammad A; Lowe ED; McDonough MA; Shaw Stewart PD; Kolek SA; Sim E; Garman EF
Acta Crystallogr D Biol Crystallogr; 2013 Aug; 69(Pt 8):1433-46. PubMed ID: 23897467
[TBL] [Abstract][Full Text] [Related]
16. Probing the architecture of the Mycobacterium marinum arylamine N-acetyltransferase active site.
Abuhammad AM; Lowe ED; Fullam E; Noble M; Garman EF; Sim E
Protein Cell; 2010 Apr; 1(4):384-392. PubMed ID: 21203950
[TBL] [Abstract][Full Text] [Related]
17. Interaction of wild type, G68R and L125M isoforms of the arylamine-N-acetyltransferase from Mycobacterium tuberculosis with isoniazid: a computational study on a new possible mechanism of resistance.
Ramos RM; Perez JM; Baptista LA; de Amorim HL
J Mol Model; 2012 Sep; 18(9):4013-24. PubMed ID: 22460521
[TBL] [Abstract][Full Text] [Related]
18. Arylamine N-acetyltransferases - of mice, men and microorganisms.
Upton A; Johnson N; Sandy J; Sim E
Trends Pharmacol Sci; 2001 Mar; 22(3):140-6. PubMed ID: 11239577
[TBL] [Abstract][Full Text] [Related]
19. Functional and structural characterization of the arylamine N-acetyltransferase from the opportunistic pathogen Nocardia farcinica.
Martins M; Pluvinage B; Li de la Sierra-Gallay I; Barbault F; Dairou J; Dupret JM; Rodrigues-Lima F
J Mol Biol; 2008 Nov; 383(3):549-60. PubMed ID: 18778714
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism p.Val231Ile alters substrate selectivity of drug-metabolizing arylamine N-acetyltransferase 2 (NAT2) isoenzyme of rhesus macaque and human.
Tsirka T; Boukouvala S; Agianian B; Fakis G
Gene; 2014 Feb; 536(1):65-73. PubMed ID: 24333853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
